- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
ANGEN
IST
Week ended 07 Aug 2026
Weekly Investor Report
Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. · Healthcare · Medical Devices
Latest close
9.10 TRY
-3.5%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -16.3% below the Trend Line and sits at 1.7% of its 52-week range. The latest completed week returned -3.5%, after a -11.4% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
15
out of 100
Latest Close
9.10 TRY
7 Aug 2026
1W Return
-3.5%
latest completed week
4W Return
-11.4%
short-term follow-through
12W Return
-29.2%
quarterly tape
Trend Breadth
25.0%
13 of 52 weeks active
Volume Ratio
0.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-3.5%
Latest completed week; four-week move -11.4%.
Indicator stack
14/14
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -16.3% below the Trend Line and sits at 1.7% of its 52-week range. The latest completed week returned -3.5%, after a -11.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0412-week average 0.22
12-week confirmation
Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.04Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -11.4% over four weeks, -29.2% over 12 weeks, and -26.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year13
Trend breadth25.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.01Latest activity-pressure read.
Pressure change-216.3%Four-week change in activity pressure.
Leadership-27.40Latest relative-leadership reading.
RS change-16.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-43.1%Distance below the 52-week high.
13-week volatility4.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+19.7%Week of 8 May.
Worst week-14.5%Week of 22 May.
Latest week-3.5%Week of 7 Aug.
Shape of recent returns
Strong gains2
Modest gains9
Flat weeks0
Modest losses12
Sharp losses3
Recent vol4.1%13-week weekly-return volatility.
Base vol5.7%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew4.0% / -4.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTR Healthcare
4-week rank13 / 15
Group average-1.9%
Trend breadth40.0%
Trend40.0%active weekly trend signals
MD33.3%positive activity pressure
RS26.7%positive relative leadership
Four-week leaders
IndustryTR Medical Devices
4-week rank3 / 3
Group average-8.3%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD0.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape18/100
Trend, activity pressure, participation, and risk combine to a 18/100 tape read.
Indicator analysis22/100Latest 12-week confirmation: trend 1/12, activity pressure 6/12, relative leadership 0/12.
Activity pressure 0.04; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS Revenue Breakdown – BIST:ANGEN Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 9.10 TRY | -3.5% | 10.87 TRY | 12.72 TRY | -1.01 | -27.40 | 8.7M | Off |
| 31 Jul 2026 | 9.43 TRY | -7.1% | 10.93 TRY | 12.75 TRY | -0.87 | -23.73 | 7.8M | Off |
| 24 Jul 2026 | 10.15 TRY | -0.9% | 10.98 TRY | 12.79 TRY | -0.68 | -21.41 | 10.6M | Off |
| 17 Jul 2026 | 10.24 TRY | -0.3% | 11.02 TRY | 12.82 TRY | -0.48 | -21.47 | 12.3M | Off |
| 10 Jul 2026 | 10.27 TRY | -2.1% | 11.05 TRY | 12.84 TRY | -0.32 | -23.63 | 19.8M | Off |
| 3 Jul 2026 | 10.49 TRY | -2.6% | 11.10 TRY | 12.86 TRY | -0.11 | -23.01 | 4.6M | Off |
| 26 Jun 2026 | 10.77 TRY | 2.5% | 11.14 TRY | 12.88 TRY | 0.06 | -20.61 | 13.4M | Off |
| 19 Jun 2026 | 10.51 TRY | -3.2% | 11.15 TRY | 12.90 TRY | 0.17 | -25.40 | 2.3M | Off |
| 12 Jun 2026 | 10.86 TRY | -2.3% | 11.19 TRY | 12.91 TRY | 0.32 | -19.09 | 10.4M | Off |
| 5 Jun 2026 | 11.12 TRY | 0.2% | 11.20 TRY | 12.92 TRY | 0.69 | -16.17 | 2.4M | On |
| 29 May 2026 | 11.10 TRY | 1.0% | 11.23 TRY | 12.94 TRY | 1.05 | -16.62 | 8.7M | Off |
| 22 May 2026 | 10.99 TRY | -14.5% | 11.28 TRY | 12.95 TRY | 1.07 | -18.88 | 45.1M | Off |
| 15 May 2026 | 12.85 TRY | -3.9% | 11.31 TRY | 12.95 TRY | 1.09 | -9.51 | 200.9M | Off |
| 8 May 2026 | 13.37 TRY | 19.7% | 11.26 TRY | 12.93 TRY | 0.74 | -10.63 | 28.3M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.